Literature DB >> 20549847

Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection.

Laurent Hocqueloux1, Thierry Prazuck, Véronique Avettand-Fenoel, Alain Lafeuillade, Bernard Cardon, Jean-Paul Viard, Christine Rouzioux.   

Abstract

Five out of 32 patients who received very early and prolonged antiretroviral therapy displayed an unusual, sustained immunovirological control after treatment discontinuation (mean duration: 77 months). These 'post-treatment controllers' did not have the genetic characteristics of spontaneous 'elite' controllers, although they shared very low and stable level of viral reservoir. Treatment may have dramatically decreased this reservoir and preserved potent HIV-specific immunologic responses, inducing a new balance between the virus and the host's immune system in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549847     DOI: 10.1097/qad.0b013e32833b61ba

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  90 in total

1.  Conference highlights of the 5th international workshop on HIV persistence during therapy, 6-9 December 2011, St. Maartin, West Indies.

Authors:  Mario Stevenson; Nicolas Chomont; Alain Lafeuillade
Journal:  AIDS Res Ther       Date:  2012-03-12       Impact factor: 2.250

Review 2.  Post-Treatment Controllers: Role in HIV "Cure" Research.

Authors:  Leslie R Cockerham; Hiroyu Hatano; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

3.  Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.

Authors:  Cynthia L Gay; Mark A DeBenedette; Irina Y Tcherepanova; Alicia Gamble; Whitney E Lewis; Anna B Cope; JoAnn D Kuruc; Kara S McGee; Mary F Kearney; John M Coffin; Nancie M Archin; Charles B Hicks; Joseph J Eron; Charles A Nicolette; David M Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-21       Impact factor: 2.205

Review 4.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 5.  Kill: boosting HIV-specific immune responses.

Authors:  Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

6.  Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

Authors:  Francesco Marras; Anna Casabianca; Federica Bozzano; Maria Libera Ascierto; Chiara Orlandi; Antonio Di Biagio; Emanuele Pontali; Chiara Dentone; Giancarlo Orofino; Laura Nicolini; Lucia Taramasso; Mauro Magnani; Francesco M Marincola; Ena Wang; Lorenzo Moretta; Andrea De Maria
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

7.  Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.

Authors:  Zelda Euler; Galit Alter
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

8.  Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.

Authors:  Cynthia L Gay; Sarah J Willis; Anna B Cope; JoAnn D Kuruc; Kara S McGee; Joe Sebastian; Amanda M Crooks; Mehri S McKellar; David M Margolis; Susan A Fiscus; Charles B Hicks; Guido Ferrari; Joseph J Eron
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

9.  How a single patient influenced HIV research--15-year follow-up.

Authors:  Heiko Jessen; Todd M Allen; Hendrik Streeck
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

10.  Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.

Authors:  Silvia Baroncelli; Maria Franca Pirillo; Clementina Maria Galluzzo; Anna Degli Antoni; Nicoletta Ladisa; Daniela Francisci; Gabriella d'Ettorre; Daniela Segala; Angela Vivarelli; Federica Sozio; Oscar Cirioni; Liliana Elena Weimer; Vincenzo Fragola; Giustino Parruti; Marco Floridia
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.